Trends in the use of local intervention for metastatic hormone‐naïve prostate cancer: A multicenter retrospective study
International Journal of Urology · 2023
DOI: 10.1111/iju.15240 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift International Journal of Urology, 2023. Verfasst von Ryuma Tanaka und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Hirosaki University Graduate School of Medicine, Hirosaki, Japan. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Prostatic Neoplasms, Castration-Resistant. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 29 Literaturangaben. Gefördert von: Japan Society for the Promotion of Science.
Abstract (Originalsprache)
Objective
To evaluated the trends of local intervention and their impact on oncological outcomes in metastatic hormone‐naïve prostate cancer (mHNPC) in real‐world practice.
Methods
This retrospective multicenter study included 760 patients treated with either androgen deprivation therapy (ADT) without local treatment (no castration‐resistant prostate cancer [CRPC] progression within 12 months, control group) or ADT plus local intervention (intervention group) between January 2005 and March 2022. We evaluated the trends in the use of local intervention in patients with mHNPC and factors associated with CRPC‐free survival in the intervention group.
Results
The use of local intervention gradually increased in combination with upfront combination treatment (docetaxel or androgen receptor axis‐targeted agents) for the duration of our study. The number of patients with local intervention combined with upfront treatment was significantly higher in patients with high tumor burden disease than in those with low tumor burden disease. Of the 108 patients who received local intervention, a duration of ≤7 months of initial therapy before local intervention and a level of prostate‐specific antigen ≥0.20 ng/mL at the time of local intervention were significantly associated with poor CRPC‐free survival.
Conclusions
The use of local intervention in combination with upfront therapy to treat mHNPC increased for the duration of our study regardless of the tumor burden. Local intervention in addition to the standard of care for mHNPC may be a feasible treatment option for selected patients, taking into consideration the duration of and response to initial treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Urology, Hirosaki University Graduate School of Medicine, Hirosaki, Japan.
- Department of Advanced Blood Purification Therapy, Hirosaki University Graduate School of Medicine, Hirosaki, Japan.
- Department of Urology, Akita University Graduate School of Medicine, Akita, Japan.
- Department of Urology, Yamagata University Graduate School of Medicine, Yamagata, Japan.
- Department of Urology, Aomori Prefectural Central Hospital, Aomori, Japan.
- Department of Urology, Miyagi Cancer Center, Natori, Japan.
ORCID-Profile: Shingo Hatakeyama, Shintaro Narita, Koji Mitsuzuka, Norihiko Tsuchiya
Förderung
- Japan Society for the Promotion of Science
Zitieren
APA
Tanaka, R., Hatakeyama, S., Narita, S., Sakurai, T., Tanaka, T., Miura, H., Oishi, T., Kawamura, S., Hoshi, S., Ishidoya, S., Mitsuzuka, K., Ito, A., Tsuchiya, N., Habuchi, T., & Ohyama, C. (2023). Trends in the use of local intervention for metastatic hormone‐naïve prostate cancer: A multicenter retrospective study. International Journal of Urology. https://doi.org/10.1111/iju.15240
Vancouver
Tanaka R, Hatakeyama S, Narita S, Sakurai T, Tanaka T, Miura H, et al. Trends in the use of local intervention for metastatic hormone‐naïve prostate cancer: A multicenter retrospective study. International Journal of Urology. 2023. doi:10.1111/iju.15240
BibTeX
@article{Tanaka2023,
author = {Tanaka, Ryuma and Hatakeyama, Shingo and Narita, Shintaro and Sakurai, Toshihiko and Tanaka, Toshikazu and Miura, Hikari and Oishi, Takuya and Kawamura, Sadafumi and Hoshi, Senji and Ishidoya, Shigeto and Mitsuzuka, Koji and Ito, Akihiro and Tsuchiya, Norihiko and Habuchi, Tomonori and Ohyama, Chikara},
title = {Trends in the use of local intervention for metastatic hormone‐naïve prostate cancer: A multicenter retrospective study},
journal = {International Journal of Urology},
year = {2023},
doi = {10.1111/iju.15240}
}
EUVIMED